High PD-L1/IDO-2 and PD-L2/IDO-1 Co-Expression Levels Are Associated with Worse Overall Survival in Resected Non-Small Cell Lung Cancer Patients

Programmed death ligand 1 (PD-L1) expression is a predictive biomarker of the success of PD-1/PD-L1 inhibitor therapy for patients with advanced non-small cell lung cancer (NSCLC) but its role as a prognostic marker for early-stage resectable NSCLC remains unclear. We studied gene expression levels...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Genes (Basel)
Main Authors: Ludovini, Vienna, Bianconi, Fortunato, Siggillino, Annamaria, Vannucci, Jacopo, Baglivo, Sara, Berti, Valeria, Tofanetti, Francesca Romana, Reda, Maria Sole, Bellezza, Guido, Mandarano, Martina, Belladonna, Maria Laura, Metro, Giulio, Chiari, Rita, Sidoni, Angelo, Puma, Francesco, Minotti, Vincenzo, Roila, Fausto
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7918978/
https://ncbi.nlm.nih.gov/pubmed/33671892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes12020273
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares